TELA Bio, Inc. TELA made its public debut on Friday morning, opening at $13.75 after being priced at $13 per share.
The company listed its shares on the Nasdaq under the ticker symbol "TELA."
TELA Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
Jefferies and Piper Jaffray are acting as joint book-running managers for the offering. Canaccord Genuity is acting as lead manager and JMP Securities is acting as co-manager.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
